Clal Insurance Enterprises Holdings Ltd sold 20,000 shares as Nice Ltd Sponsored Adr (NICE)’s stock rose 7.66%. Bank of Montreal Can now owns 9,914 shares of the software maker’s stock worth $126,000 after buying an additional 3,724 shares during the period. The firm’s market cap is $2.34 billion. The stock declined 0.08% or $0.03 reaching $39.44 on the news. It has outperformed by 17.71% the S&P500. Mason Street Advisors Ltd Llc has invested 0.02% in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX). Jefferies maintained Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) rating on Monday, July 24. Retirement Systems of Alabama now owns 338,843 shares of the software maker’s stock valued at $4,297,000 after buying an additional 99,827 shares in the last quarter. Anthem now has $50.88B valuation.
The stock decreased 0.15% or $0.02 on August 25, reaching $12.94. Its share price has risen 0.01% in three months and is down -1.02% for the last five trades. Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) has declined 8.32% since August 26, 2016 and is downtrending. It has underperformed by 25.02% the S&P500.The move comes after 6 months positive chart setup for the $2.34 billion company.
Since March 23, 2017, it had 0 buys, and 2 selling transactions for $475,850 activity. Gideon Cap Advisors owns 0.23% invested in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) for 35,492 shares.
Allscripts Healthcare Solutions, Inc. delivers information technology (IT) solutions and services to help healthcare organizations.
Investors sentiment increased to 1.09 in 2016 Q4. Its up 0.02, from 1.03 in 2016Q3.
Want to see what other hedge funds are holding MDRX? 38 funds opened positions while 76 raised stakes. The volume of PBCT witnessed a shift from 1.22 million shares, based on a 50-day average, to 2.83 million shares. Airain Ltd invested in 0.05% or 63,848 shares. Swiss Bank has 0% invested in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) for 291,400 shares. Bnp Paribas Arbitrage Sa reported 57,506 shares stake.
FT reports, The 21 analysts offering 12 month price targets for Autodesk, Inc. have a median target of 120.00, with a high estimate of 138.00 and a low estimate of 51.00. First Trust Advsrs Limited Partnership holds 3.96 million shares or 0.12% of its portfolio. World Asset Management Inc, Michigan-based fund reported 11,324 shares. For the full year, analysts expect earnings to jump 12.5% yoy to $0.45. Manufacturers Life Insur The owns 252,290 shares for 0% of their portfolio. Moreover, Paradigm Capital Management Inc Ny has 1.97% invested in the company for 1.99 million shares. It last reported revenues of $427.7 million and EPS of $0.15 for the June 2017, representing 8% top-line growth and 0.14 EPS growth.
Allscripts Healthcare Solutions (NASDAQ:MDRX) had an increase of 0.91% in short interest. Atlantic Gru Lc holds 0% or 32,790 shares.
Iguana Healthcare Management Llc increased Chemocentryx Inc (NASDAQ:CCXI) stake by 120,000 shares to 270,000 valued at $2.00M in 2016Q4. Ancora Advisors Llc holds 0.15% or 207,891 shares. Acceleron Pharma Inc (NASDAQ:XLRN) was raised too. (NASDAQ:MDRX) traded up 0.46% in the last session while performance was up 12.99% in the last five days. Therefore 45% are positive. MDRX was included in 7 notes of analysts from August 5, 2015. Topeka Capital Markets maintained the shares of MDRX in report on Wednesday, August 5 with “Hold” rating.
Allscripts Healthcare Solutions (NASDAQ:MDRX) last posted its quarterly earnings results on Thursday, August 3rd.
A number of research analysts recently issued reports on MDRX shares. Cantor Fitzgerald reaffirmed a “buy” rating and set a $17.00 price objective (up from $15.00) on shares of Allscripts Healthcare Solutions in a report on Monday, August 14th. They now have a Dollars 16.5 price target on the stock. The stock of Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) earned “Sector Perform” rating by RBC Capital Markets on Wednesday, August 5. The stock has “Buy” rating by Maxim Group on Tuesday, January 10. JP Morgan reinitiated Nice Ltd (ADR) (NASDAQ:NICE) on Wednesday, June 29 with “Overweight” rating. The forecast of 16 surveyed investment analysts covering the stock advises investors to Buy stake in the company. NICE Systems had 16 analyst reports since July 30, 2015 according to SRatingsIntel. The stock has “Neutral” rating by Bank of America on Friday, October 7. The stock has “Overweight” rating by Piperjaffray on Friday, September 23. Oppenheimer maintained the stock with “Hold” rating in Friday, August 4 report. The rating was initiated by First Analysis on Tuesday, December 1 with “Overweight”. On Monday, March 27 the stock rating was upgraded by Wells Fargo to “Outperform”.